D-Cyclohexylglycine

D-Cyclohexylglycine is a chiral amino acid derivative featuring a D-configured α-amino acid backbone bearing a cyclohexyl side chain, which functions as a hydrophobic, sterically defined substituent for molecular recognition and peptide backbone mimicry. The molecule contains a primary amine and a carboxylic acid, enabling standard amino acid coupling chemistry and salt formation while maintaining a stereogenic center that can influence conformational preferences in peptides and peptidomimetics. The saturated cyclohexyl group provides chemical robustness toward common peptide-coupling conditions and can modulate lipophilicity, membrane affinity, and binding-site shape complementarity in structure-activity relationship (SAR) studies. As a chiral amino acid building block, D-Cyclohexylglycine can be incorporated directly into protected-amino-acid workflows or used as a synthetic intermediate for downstream functionalization and industrial fine chemical synthesis.

1. Peptide Synthesis

D-Cyclohexylglycine is used in peptide synthesis and peptidomimetic construction where the D-stereochemistry and cyclohexyl side chain contribute to conformational control and hydrophobic side-chain display. The free amino and carboxyl functionalities participate in standard amide bond formation after conversion to an N-protected amino acid derivative and, when needed, a C-terminal activated form. Side-chain hydrophobicity and steric bulk can be leveraged to tune solubility and backbone geometry in short peptide analogs and enzyme-substrate mimics. Incorporation into peptide coupling sequences supports the generation of stereochemically defined libraries for SAR studies and biochemical research intermediate preparation.

2. Chiral Building Block

D-Cyclohexylglycine serves as a chiral amino acid intermediate for stereoselective synthesis of cyclohexyl-substituted fragments used in medicinal chemistry and industrial fine chemical production. The D-configured α-carbon provides a fixed stereochemical handle that can be retained through protection, activation, and coupling steps, supporting consistent stereochemical outcomes in downstream derivatives. The cyclohexyl side chain can be carried through multi-step syntheses as a robust hydrophobic group, while the amino acid functionality enables conversion to protected forms for controlled reactivity. The resulting D-configured intermediates can be applied to the preparation of chiral amides, chiral ligands, and peptide-building blocks used in applied product development.

3. Side-Chain Functionalization

D-Cyclohexylglycine is applicable to amino acid derivatization strategies that introduce additional functional groups for conjugation or property tuning without disrupting the stereogenic center. The carboxylic acid can be transformed into activated esters or protected acid derivatives to enable selective coupling to amines, while the amino group can be protected to permit orthogonal modifications. The cyclohexyl side chain can be used as a hydrophobic scaffold for subsequent functional group installation on the amino acid-derived framework, supporting generation of analogs with altered partitioning, binding-site occupancy, or receptor-contact geometry. Downstream products produced from D-Cyclohexylglycine can function as biochemical research intermediates for structure-function mapping and as feedstocks for specialty chemical production.

4. SAR Studies

D-Cyclohexylglycine is employed in structure-activity relationship studies where a D-amino acid with a cyclohexyl side chain provides a defined steric and hydrophobic element for systematic variation. The stereochemical inversion relative to the L-series can influence peptide folding propensity and side-chain orientation, enabling SAR comparisons across stereoisomeric analogs. The amino acid backbone supports incorporation into peptide analogs and peptidomimetics through amide coupling-compatible protection strategies, allowing consistent comparison of analog series. Cyclohexyl substitution helps probe hydrophobic pocket engagement and conformational tolerance, supporting iterative molecular design cycles in biochemical research and applied synthetic methodology.

5. Pharmaceutical Manufacturing

D-Cyclohexylglycine is suitable for pharmaceutical intermediate preparation and process chemistry routes that require robust, stereodefined amino acid building blocks for controlled synthesis of peptide-like structures. The amino acid functionality can be converted into N-protected forms and activated derivatives compatible with scalable peptide coupling chemistry, while the saturated cyclohexyl side chain tolerates common manufacturing conditions without introducing reactive heteroatoms. The D-stereocenter supports reproducible stereochemical outcomes in manufacturing workflows that generate chiral amide intermediates and peptide fragments. Material generated from D-Cyclohexylglycine can be used as a defined input for downstream fine chemical synthesis and for producing stereochemically consistent peptide-based intermediates used in industrial development programs.

6. Analytical Research

D-Cyclohexylglycine can be used as an analytical reference material and biochemical research reagent for method development involving chiral amino acid detection and peptide hydrolysate profiling. The presence of a single, well-defined D-configured stereocenter and a distinctive cyclohexyl side chain supports chromatographic differentiation from other amino acids and from L-analogues. Carboxyl and amino functionalities enable derivatization approaches that improve detectability in mass spectrometry and chromatographic assays, supporting quantitative analysis of amino acid incorporation in peptide building block workflows. Use of D-Cyclohexylglycine in analytical research supports accurate characterization of stereochemical identity and composition in peptide science and applied amino acid chemistry.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

4. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

5. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes